TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2015

Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years.

Aldiouma Diallo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.